MuGenics develops point-of-care molecular diagnostic kits that deliver gene-level insights in 20-45 minutes, enabling clinicians to make precise, timely treatment decisions.
Isothermal amplification delivers clinical-grade molecular results at the bedside - no laboratory infrastructure required.
Gene-level detection of pathogens and resistance markers enables targeted, evidence-based treatment from day one.
Affordable, ambient-stable, and scalable - engineered for diverse settings from ICUs to rural clinics.
A focused mission to combat antimicrobial resistance through rapid, actionable diagnostics at the point of care.
Custom-selected high-affinity aptamers provide exceptional target selectivity for precise pathogen and biomarker detection.
Built on peer-reviewed science, validated in real ICU environments. Incubated at SRM BioNEST, Kattankulathur.
MuGenics Private Limited is a molecular diagnostics startup advancing next-generation solutions for infectious disease detection and antimicrobial resistance. We integrate isothermal amplification, lateral flow detection, aptamer technology, and microfluidics to create fast, portable diagnostic systems.
From sample to answer, no thermal cycler required.
Targeting leptospirosis, STIs, AMR, and more.
SRM BioNEST, SRM Medical College Hospital & Research Centre
Infectious disease · AMR · STI · Field diagnostics
Every product decision flows from one purpose: give clinicians the molecular clarity they need, exactly when and where they need it.
To deliver accessible, high-accuracy molecular diagnostics that enable rapid detection and informed treatment decisions across diverse healthcare settings.
To become a leader in innovative, affordable, and clinically impactful diagnostic technologies addressing critical healthcare challenges in India and globally.
Each kit delivers molecular-level insights without complex instrumentation - engineered for speed, precision, and point-of-care accessibility.
Rapid molecular detection of Leptospira species for early diagnosis and timely clinical intervention.
✉ EnquirySuitable for point-of-care and field use, using isothermal amplification with no thermal cycler required.
High-precision molecular detection of Neisseria gonorrhoeae supporting rapid, decentralised STI diagnosis.
✉ EnquiryDesigned for rapid STI diagnosis in clinical and decentralised settings with molecular-level accuracy.
Reliable, rapid molecular detection of syphilis for early diagnosis and management across clinical settings.
✉ EnquirySuitable for clinical and decentralised healthcare settings with ambient-stable reagents and a user-friendly workflow.
A rapid, point-of-care molecular kit for comprehensive detection of antimicrobial resistance genes directly from clinical specimens.
✉ Register InterestDesigned for ICU and bedside use, delivering actionable carbapenemase and ESBL resistance profiles in under 60 minutes without sequencing infrastructure.
Our diagnostic kits are built on two complementary molecular detection platforms, each selected for the specific needs of the target application.
LAMP-LFA - Loop-mediated isothermal amplification coupled with lateral flow detection
Our isothermal nucleic acid amplification platform enables rapid, sensitive detection of bacterial and viral pathogens without complex instrumentation. Reactions run at constant temperature, eliminating the need for a thermal cycler.
Constant-temperature reactions, no specialised equipment
Sample to clinically actionable answer
Low-copy target detection with clinical precision
Portable, no lab infrastructure needed
SELEX-derived aptamers coupled with lateral flow for label-free molecular recognition
Aptamers are short, single-stranded nucleic acid molecules selected to bind specific target molecules with high affinity and selectivity. Generated through SELEX, our aptamers provide antibody-like precision without cold-chain requirements.
Target-selective binding comparable to antibodies
No cold chain, ambient storage
Chemical synthesis, no biological manufacturing
Adaptable to diverse pathogens and biomarkers
Beyond our product pipeline, MuGenics offers expert molecular and diagnostic services to clinical, research, and institutional partners.
Comprehensive testing and analysis of drug-resistant pathogens including carbapenem resistance and ESBL profiling for clinical and research use.
✉ EnquiryNGS-based microbial profiling for pathogen detection, microbiome characterisation, and data-driven clinical insights across diverse specimen types.
✉ EnquiryCustom workflows for protein production, purification, and characterisation for research and industrial applications.
✉ EnquiryEnd-to-end solutions including vector design, gene cloning, and construct development for research and diagnostic assay development.
✉ EnquiryCustom high-affinity aptamers for diagnostics, biosensors, and therapeutic applications using systematic evolution of ligands by exponential enrichment.
✉ EnquiryExpert guidance in molecular diagnostics, AMR detection, and laboratory setup, with professional training programmes for clinical and research personnel.
✉ EnquiryWhether you are a clinician, institution, investor, or research partner - every enquiry is welcome.
No. 46, Indra Nagar, Ninnakarai Village, Kattankolathur, Chengalpattu, Kanchipuram - 603203, Tamil Nadu
SRM BioNEST, SRM Medical College Hospital & Research Centre, Kattankulathur
Clinical Partnerships · Investment · Research Collaboration · Licensing
Delivered directly to mugenics.dx@gmail.com - we respond within 2 business days.
Thank you for reaching out. We'll get back to you at mugenics.dx@gmail.com